IS7888A - Fínasteríðsamsetningar - Google Patents

Fínasteríðsamsetningar

Info

Publication number
IS7888A
IS7888A IS7888A IS7888A IS7888A IS 7888 A IS7888 A IS 7888A IS 7888 A IS7888 A IS 7888A IS 7888 A IS7888 A IS 7888A IS 7888 A IS7888 A IS 7888A
Authority
IS
Iceland
Prior art keywords
fínasteríðsamsetningar
Prior art date
Application number
IS7888A
Other languages
English (en)
Other versions
IS2943B (is
Inventor
Johannsson Fjalar
Irnason Birkir
Original Assignee
Actavis Group Hf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group Hf. filed Critical Actavis Group Hf.
Publication of IS7888A publication Critical patent/IS7888A/is
Publication of IS2943B publication Critical patent/IS2943B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS7888A 2002-11-22 2005-06-10 Fínasteríðsamsetningar IS2943B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum
PCT/IS2003/000034 WO2004047798A2 (en) 2002-11-22 2003-11-21 Formulations of finasteride

Publications (2)

Publication Number Publication Date
IS7888A true IS7888A (is) 2005-06-10
IS2943B IS2943B (is) 2016-03-15

Family

ID=36700777

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum
IS7888A IS2943B (is) 2002-11-22 2005-06-10 Fínasteríðsamsetningar

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum

Country Status (5)

Country Link
US (1) US20060099251A1 (is)
EP (1) EP1575555B1 (is)
AU (1) AU2003302372A1 (is)
IS (2) IS6633A (is)
WO (1) WO2004047798A2 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
HRP20160625T1 (hr) * 2007-09-10 2016-08-12 Boston Biomedical, Inc. Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka
ES2987670T3 (es) 2010-03-19 2024-11-15 1Globe Biomedical Co Ltd Métodos novedosos para actuar sobre células madre cancerosas
JP5902184B2 (ja) 2010-11-22 2016-04-13 華安醫學股分有限公司Ｅｎｅｒｇｅｎｅｓｉｓ Ｂｉｏｍｅｄｉｃａｌ Ｃｏ．， Ｌｔｄ． 毛髪成長促進剤、睫毛と眉毛の成長促進剤、および脱毛防止剤
ES2784026T3 (es) 2010-12-15 2020-09-21 Energenesis Biomedical Co Ltd Uso no terapéutico de una composición para promover el crecimiento del cabello
CA2908380A1 (en) 2013-04-09 2014-10-16 Boston Biomedical, Inc. Methods for treating cancer
EP3002005A1 (en) * 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direct compression excipient based on lactose, cellulose and starch
EP3493810A4 (en) * 2016-08-02 2020-04-08 Durect Corporation COMPOSITIONS WITH OXYGENOUS CHOLESTERINSULFATE AND AT LEAST POLYALKYLENE GLYCOL, CARBOXYMETHYLCELLULOSE OR POLYOXYL GLYCERIDE
WO2018102427A1 (en) 2016-11-29 2018-06-07 Boston Biomedical, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
WO2018213424A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer
CN108853047A (zh) * 2018-07-25 2018-11-23 江苏黄河药业股份有限公司 一种非那雄胺片及其制备方法
CN109453134A (zh) * 2018-12-03 2019-03-12 海南赛立克药业有限公司 一种含非那雄胺的药物组合物及其制备方法
GB2610163B (en) * 2021-08-12 2023-12-13 Netriver Systems Ltd Secure online exchange of digital identification

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
GB9717444D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
GB9717428D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
DE69811233T2 (de) * 1997-10-27 2003-11-20 Merck Patent Gmbh Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
AU2003302372A1 (en) 2004-06-18
WO2004047798A2 (en) 2004-06-10
EP1575555A2 (en) 2005-09-21
AU2003302372A8 (en) 2004-06-18
EP1575555B1 (en) 2014-08-06
IS6633A (is) 2004-05-23
US20060099251A1 (en) 2006-05-11
IS2943B (is) 2016-03-15
WO2004047798A3 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
ATE457980T1 (de) Aryloxime
ATE534648T1 (de) C-6-modifizierte indazolylpyrrolotriazine
NO20043626L (no) Formoterolsuperfinformulering
DE50305852D1 (de) Einspritzventil
DE50306589D1 (de) Wischblatt
DE50310083D1 (de) Phthalocyaninpigmentzubereitungen
ATE427876T1 (de) Luftkissenboot
ATE318817T1 (de) Aza-arylpiperazine
DE50212360D1 (de) Anfahrhilfesteuerungsvorrichtung
DE50305301D1 (de) Einspritzventil
ATE349458T1 (de) Etonogestrelester
DE50309536D1 (de) Fadenabsaugvorrichtung
DE50310481D1 (de) Röntgenstativ
ATA1572002A (de) Managementspleisskassette
DE50302660D1 (de) Stopfmachine
DE50307971D1 (de) Gelenklager
IS7888A (is) Fínasteríðsamsetningar
DE50301960D1 (de) Hydrolager
ATA4142004A (de) Trägerverbau
ATE469773T1 (de) Zugöse
DE50303317D1 (de) Einschub-leistungsschalter
DE50209283D1 (de) Tropfbewässerungsrohr
DE50307628D1 (de) Getraenkehalter
ATA19152002A (de) Hubkupplung
DE50308979D1 (de) Einspritzventil